Nanexa's atomic layer deposition (ALD) platform PharmaShell® demonstrably improves the pharmacokinetic profile of semaglutide injections.Significantly smoother plasma concentration curve could mitigat ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects healthy upside for Novo Nordisk stock through ...

Dr Elise Dallas, GP at The London General Practice, explains how these medications impact our bodies and what happens after you stop taking them.

Afrezza is a rapid-acting inhaled human insulin indicated to improve glycemic control in adults with diabetes mellitus.

The new generic drug has been approved for treatment of bovine respiratory disease and associated pyrexia in beef and ...

He cited one study, which found an average a return to baseline weight in around 1.5 years after taking the medications.

Updated initial conversion table based on clinical trials in adults showing significantly improved mealtime glycemic ...

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...

Assistant Controller of Patents (C.A. (COMM.IPD-PAT) 76/2022), the Delhi High Court upheld the refusal of a patent ...